EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 36 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,000 | -90.5% | 300 | -78.3% | 0.00% | -100.0% |
| Q4 2019 | $21,000 | +40.0% | 1,380 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $15,000 | +650.0% | 1,512 | +950.0% | 0.00% | – |
| Q2 2019 | $2,000 | -88.9% | 144 | -89.1% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | -88.8% | 1,323 | -91.6% | 0.00% | -90.9% |
| Q4 2018 | $160,000 | -53.9% | 15,779 | -45.5% | 0.01% | -45.0% |
| Q3 2018 | $347,000 | +984.4% | 28,954 | +898.4% | 0.02% | +566.7% |
| Q3 2017 | $32,000 | -43.9% | 2,900 | -59.7% | 0.00% | -40.0% |
| Q2 2017 | $57,000 | – | 7,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $6,144,000 | 4.00% |
| P.A.W. CAPITAL CORP | 380,000 | $3,363,000 | 2.96% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,770,000 | 1.78% |
| Telemetry Investments, L.L.C. | 150,477 | $1,332,000 | 1.51% |
| 683 Capital Management, LLC | 2,683,600 | $23,750,000 | 1.26% |
| KNOTT DAVID M | 276,535 | $2,447,000 | 1.05% |
| Trellus Management Company, LLC | 226,000 | $2,000,000 | 1.04% |
| TOWERVIEW LLC | 140,000 | $1,239,000 | 0.77% |
| Vivo Capital, LLC | 1,791,257 | $15,853,000 | 0.56% |
| CAXTON CORP | 94,083 | $833,000 | 0.54% |